Melinta Therapeutics INC /New
New Haven, US
Biotech
Founders & leadership
JH
John H. JohnsonDirector
DJ
David J. GillDirector
GP
Garheng P. KongDirector
DP
David P. ZaccardelliDirector
ST
Sue T. CammarataExecutive Vice President and Chief Medical Officer
KT
Kevin T. FerroChairman of the Board
TP
Thomas P. KoestlerDirector
JJ
Jay J. Galeota, Jr.Director
DW
Daniel WechslerDirector, President and Chief Executive Officer
CJ
Cecilia J. GonzaloDirector
ET
Erin T. DuffyExecutive Vice President and Chief Scientific Officer
PT
Paul T. EstremExecutive Officer
Reported raises · per SEC filings
Form D private placements$137.8MraisedJan 2018 · 9 investors · Pharmaceuticals
Rule 506(b)$132.9MraisedNov 2017 · 39 investors · Pharmaceuticals
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.